2013 Fiscal Year Final Research Report
Analysis of vascular endothelial growth factor as novel therapeutic target for methylmercury poisoning
| Project/Area Number |
24659426
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Niigata University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAKAHASHI Tetsuya 新潟大学, 医歯学総合病院, 助教 (20515663)
USUKI Fusako 国立水俣病総合研究センター, 臨床部, 室長 (50185013)
FUJIMURA Masatake 国立水俣病総合研究センター, 基礎研究 部・病理室, 室長 (20416564)
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Keywords | 水俣病 / メチル水銀中毒 / 血管内皮細胞増殖因子 / 血液脳関門 |
|---|
| Research Abstract |
Minamata disease and Niigata Minamata disease are methylmercury poisoning in Japan caused by environmental pollution. We analyzed the mechanism by which methyl-mercury causes brain damage from a standpoint of blood brain barrier (BBB) damage. We demonstrated that methylmercury caused up-regulation of vascular endothelial growth factor (VEGF) in rat brain, and caused BBB damage. We also demonstrated that VEGF inhibition by anti-VEGF neutralizing antibody may ameliorate brain damage associated with methylmercury poisoning.
|
